RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients
Stock Information for Redhill Biopharma Ltd.
Loading
Please wait while we load your information from QuoteMedia.